Mar 12 |
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
|
Mar 11 |
ClearPoint Neuro Q4 2023 Earnings Preview
|
Mar 11 |
Earnings Outlook For ClearPoint Neuro
|
Mar 11 |
Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System
|
Mar 1 |
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
|
Feb 29 |
ClearPoint Neuro prices offering of about 2.3M shares
|
Feb 29 |
ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock
|
Feb 28 |
ClearPoint Neuro stock falls 10% after it announces an equity raise
|
Feb 28 |
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
|
Feb 21 |
ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model
|